Baiya Phytopharm Co., Ltd.
Clinical Trials
3
Active:1
Completed:1
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)Evaluation of Safety, Tolerability, Reactogenicity, Immunogenicity of Baiya SARS-CoV-2 Vax 2 as a Booster for COVID-19
Phase 2
Not yet recruiting
- Conditions
- COVID-19COVID-19 Vaccine
- First Posted Date
- 2023-05-24
- Last Posted Date
- 2023-11-15
- Lead Sponsor
- Baiya Phytopharm Co., Ltd.
- Target Recruit Count
- 75
- Registration Number
- NCT05873374
- Locations
- 🇹🇭
Queen Saovabha Memorial Institute, Bangkok, Thailand
Evaluation of the Safety, Tolerability, and Reactogenicity of the Baiya SARS-CoV-2 Vax 2 Vaccine for COVID-19 Disease
Phase 1
Active, not recruiting
- Conditions
- COVID-19 Vaccine
- First Posted Date
- 2022-01-19
- Last Posted Date
- 2023-05-24
- Lead Sponsor
- Baiya Phytopharm Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT05197712
- Locations
- 🇹🇭
Queen Saovabha Memorial Institute, Bangkok, Thailand
A Study to Evaluate Safety, Tolerability, and Reactogenicity of an RBD-Fc-based Vaccine to Prevent COVID-19
Phase 1
Completed
- Conditions
- Coronavirus
- First Posted Date
- 2021-07-07
- Last Posted Date
- 2023-01-12
- Lead Sponsor
- Baiya Phytopharm Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT04953078
- Locations
- 🇹🇭
Chula Clinical Research Center (Chula CRC), Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
🇹🇭Queen Saovabha Memorial Institute, Bangkok, Thailand
News
No news found